Cancer center researchers may have uncovered the specific biomarker that causes Black women to get triple-negative breast cancer at higher rates than other women.
The RELIEF™ ureteral stent has achieved FDA clearance as the first and only stent to have approval for the prevention of vesicoureteral reflux, a major cause of patient discomfort. RELIEF’s unique suture design allows natural opening and closing of the ureteral orifice, thereby preventing vesicoureteral reflux.
A study from University of Michigan researchers may provide an explanation for why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
With drills buzzing, saws slicing, and hammers pounding, Cedars-Sinai Orthopaedics once again hosted The Perry Initiative—an annual program designed to inspire young women to pursue careers in orthopedic surgery and biomedical engineering.
Throughout the United States, more than 100 million buildings tap into electrical energy to keep heating, ventilation, air conditioning and refrigeration units functioning. HVAC systems cause most of the peak load demand on the electric grid; one way to alleviate the grid burden is to develop new storage options for heating and cooling.
New findings by researchers at MSK and their collaborators at the Icahn School of Medicine point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer.
Previously in 2024, researchers at the Harvey L. Neiman Health Policy Institute published a novel risk-adjustment score—the Neiman Imaging Comorbidity Index (NICI)—predictive of patients’ advanced imaging use. Now, these researchers have published more extensive validation of the NICI to test its utility in datasets other than the claims dataset from which it was developed.
Local governments in developing countries are crucial for providing public services that promote human development and address challenges like extreme weather, unemployment and crumbling infrastructure. Yet, they often face difficulties in implementing cost-effective programs that meet citizens’ diverse needs, particularly in areas with significant socioeconomic inequalities. A recent study led by University of Notre Dame researcher Krister Andersson explored the impact of economic and social inequalities on local government performance in Chile (a country with very high socioeconomic inequalities), assessing the effectiveness of external policies to alleviate the negative effects of inequality on the quality of local public services.
The American Association of Nurse Anesthesiology (AANA) issued the following statement following Medical Mutual’s change in reimbursement policy for anesthesia:
HS PROGRESS is designed to facilitate hidradenitis suppurativa (HS) research through collaboration between investigators, clinicians, patients and industry in order accelerate the development of therapies to improve the lives of people living with this skin painful condition.
Astatine-211 (At-211) is a promising alpha emitting radioisotope for cancer therapy, but its short 7.2-hour half-life means that it must be handled quickly to minimize losses due to radioactive decay. In this research, scientists designed and tested an automated device for producing At-211 that improves production time and efficiency. The device also minimizes the dose of radioactivity to production staff and reduces the time needed to prepare samples for shipment.
At the Department of Energy’s Office of Science, 2024 brought big accomplishments enabled by decades of work as well as advances that are establishing the foundations for future research. From Nobel Prizes to a new exascale computer, the DOE’s Office of Science is leading the way.
Researchers at the Department of Energy’s Oak Ridge National Laboratory are using microwave radar reflection to nondestructively detect and measure the moisture content of materials within walls without removing drywall or cladding. This also expedites moisture identification and enables mold growth to be treated in the early stages.
University of Chicago President Paul Alivisatos has been named one of this year’s winners of the Enrico Fermi Presidential Award—one of the most prestigious science and technology honors bestowed by the U.S. government—the White House announced Dec. 19.